From Genes, Proteins, and Clinical Manifestation: Why Do We Need to Better Understand Age-Related Macular Degeneration? by Steffen Schmitz-Valckenberg, MD, Moussa A. Zouache, PhD, Gregory S. Hageman, PhD, Monika Fleckenstein, MD

Get full text

Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy by Maximilian Pfau, Steffen Schmitz-Valckenberg, Ramiro Ribeiro, Reza Safaei, Alex McKeown, Monika Fleckenstein, Frank G. Holz

Get full text

Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence by Maximilian Pfau, Elon H. C. van Dijk, Thomas J. van Rijssen, Steffen Schmitz-Valckenberg, Frank G. Holz, Monika Fleckenstein, Camiel J. F. Boon

Get full text

A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration. by Felix Grassmann, Peter G A Schoenberger, Caroline Brandl, Tina Schick, Daniele Hasler, Gunter Meister, Monika Fleckenstein, Moritz Lindner, Horst Helbig, Sascha Fauser, Bernhard H F Weber

Get full text

Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration. by Felix Grassmann, Monika Fleckenstein, Emily Y Chew, Tobias Strunz, Steffen Schmitz-Valckenberg, Arno P Göbel, Michael L Klein, Rinki Ratnapriya, Anand Swaroop, Frank G Holz, Bernhard H F Weber

Get full text

CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. by Hendrik P N Scholl, Monika Fleckenstein, Lars G Fritsche, Steffen Schmitz-Valckenberg, Arno Göbel, Christine Adrion, Christine Herold, Claudia N Keilhauer, Friederike Mackensen, Andreas Mössner, Daniel Pauleikhoff, Andreas W A Weinberger, Ulrich Mansmann, Frank G Holz, Tim Becker, Bernhard H F Weber

Get full text